Abstract

BackgroundInfections of bone and joint tissues following arthroplasty surgeries remain a major challenge in orthopaedic settings. Methicillin resistant Staphylococcus aureus (MRSA) is recognised as an established pathogen in such infections. Combination therapy using linezolid and bacteriophage impregnated in biopolymer was investigated in the present study as an alternative strategy to prevent MRSA colonisation on the orthopaedic implant surface.MethodologyCoating of stainless steel orthopaedic grade K-wires was achieved using hydroxypropylmethlycellulose (HPMC) mixed with phage alone, linezolid alone and phage and linezolid together. The potential of these agents to inhibit adhesion of S.aureus (MRSA) 43300 on K-wires was assessed. Coated and naked wires were analysed by scanning electron microscopy (SEM) and fluorescent staining.ResultSignificant reduction in bacterial adhesion was achieved on phage/linezolid wires in comparison to naked as well as HPMC coated wires. However, maximum reduction in bacterial adherence (∼4 log cycles) was observed on the wires coated with phage-linezolid combination. The frequency of emergence of resistant mutants was also negligible in presence of both the agents.ConclusionThis study provides evidence to confirm that local delivery system employing linezolid (a potent protein synthesis inhibitor) along with a broad spectrum lytic bacteriophage (capable of self-multiplication) is able to attack the adhered as well as surrounding bacteria present near the implant site. Unlike other antibiotic based therapies, this combination has the potential to significantly restrict the emergence of resistant mutants, thus paving the way for effective treatment of MRSA associated infection of medical implants.

Highlights

  • Orthopaedic devices used in joint and hip replacement surgeries have greatly improved the health outcomes for patients

  • This study provides evidence to confirm that local delivery system employing linezolid along with a broad spectrum lytic bacteriophage is able to attack the adhered as well as surrounding bacteria present near the implant site

  • Unlike other antibiotic based therapies, this combination has the potential to significantly restrict the emergence of resistant mutants, paving the way for effective treatment of Methicillin resistant Staphylococcus aureus (MRSA) associated infection of medical implants

Read more

Summary

Introduction

Orthopaedic devices used in joint and hip replacement surgeries have greatly improved the health outcomes for patients. Implant associated infections remain a major problem in hospital settings [1,2].Treatment of the open fracture exposes the sterile body sites to the external environment that leads to introduction of the pathogen either on the implant itself or into the surgical site [3].Staphylococcus aureus is a major pathogen involved in orthopaedic implant infections. After adherence, it tends to form biofilm on the implant surface, which acts as a barrier for the penetration of antibacterial compounds and host’s immune system [4,5,6]. Combination therapy using linezolid and bacteriophage impregnated in biopolymer was investigated in the present study as an alternative strategy to prevent MRSA colonisation on the orthopaedic implant surface

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call